Background and Aim: β-Arrestins (β-arrs) are regulators and mediators of G proteincoupled receptor signaling that are functionally involved in inflammation. Nuclear factor-κB p65 (NF-κBp65) activation has been observed early in the onset of pancreatitis. However, the effect of β-arrs in acute pancreatitis (AP) is unclear. The aim of this study is to investigate whether β-arrs are involved in AP through activation of NF-κBp65. Methods: Acute pancreatitis was induced by either caerulein injection or choline-deficient supplemented with ethionine diet (CDE). β-arr1 wild-type and β-arr1 knockout mice were used in the experiment. The survival rate was calculated in the CDE model mice. Histological and western blot analyses were performed in the caerulein model. Inflammatory mediators were detected by real-time polymerase chain reaction in the caerulein-induced AP mice. Furthermore, AR42J and PANC-1 cell lines were used to further study the effects of β-arr1 in caerulein-induced pancreatic cells. Results: β-Arr1 but not β-arr2 is significantly downregulated in caerulein-induced AP in mice. Targeted deletion of β-arr1 notably upregulated expression of the pancreatic inflammatory mediators including tumor necrosis factor α and interleukin 1β as well as interleukin 6 and aggravated AP in caerulein-induced mice. β-Arr1 deficiency increased mortality in mice with CDE-induced AP. Further, β-arr1 deficiency enhanced caerulein-induced phosphorylation of NF-κBp65 both in vivo and in vitro. Conclusion: β-Arr1 alleviates AP via repression of NF-κBp65 activation, and it is a potentially therapeutic target for AP.
Introduction
Acute pancreatitis (AP) is an abdominal emergency that is characterized by interstitial edema, vacuolization, and parenchymal necrosis with various inflammatory cell infiltration. [1] [2] [3] Mild AP may be self-limiting, while severe AP remains a life-threatening disease with a high mortality. 4, 5 Intra-acinar nuclear factor-κB (NF-κB) activation has been observed early in the onset of pancreatitis and is required as well as sufficient to induce inflammatory response of the pancreatitis including local inflammation and a systemic inflammatory response. 6, 7 Nuclear factor-κB is a ubiquitous inducible transcription factor that is responsible for mediating the expression of a large number of genes involved in proliferation, differentiation, inflammation, and tissue injury and repair. 8, 9 NF-κB is inactive and resides the cytoplasm. When cells are stimulated by cytokines, oxidative stress, or infection, inhibitors NF-κB (IκBs) are rapidly phosphorylated and subsequently polyubiquinated and then degraded. When IκBs are degraded, NF-κB is unmasked and translocated into the nucleus, where it binds to its cognate DNA sequence and induces the transcription of its target genes. 9, 10 Activated pancreatic NF-κB has been identified in a number of different animal models of pancreatitis such as caerulein, taurocholate, bilepancreatic duct ligation, L-arginine, as well as in clinical pancreatitis. [11] [12] [13] [14] Pyrrolidine dithiocarbamate attenuates the severity of experiment AP by inhibited NF-κB activation, and peroxisome proliferator-activated receptor γ ligand 15-PGJ2 also attenuates the severity of caerulein-induced AP through inhibited IκB degradation. 15, 16 Targeted deletion of IκBα activates RelA (NF-κBp65) to reduce AP in mice. 17 Thus, the inhibition of endogenous or exogenous NF-κBp65 activation may be a new therapeutic target for AP.
β-Arrestins (β-arrs), including β-arrestin1 (β-arr1) and β-arrestin2 (β-arr2), are multifunctional adaptor proteins that are ubiquitously distributed. The β-arrs are known for their role in binding to phosphorylated G protein-coupled receptors (GPCRs) to evoke receptor desensitization and endocytosis, which leads to numerous physiological outcomes. 18, 19 However, β-arrs have a much broader role in cell signaling related to both GPCRs and non-GPCRs. Because of their critical role in many cellular functions, β-arrs are critical in the pathogenesis of many different diseases, including cardiac dysfunction, sepsis and rheumatoid arthritis, and colitis. [20] [21] [22] [23] Deletion of β-arr1 and β-arr2 in mice results in phenotypically normal animals that produce viable progeny, but these mice display abnormal responses to physiologic stresses. 24 Although both proteins accumulate in the cytoplasm following overexpression, β-arr1, but not β-arr2, accumulates in the nucleus. 24 β-arr1 and β-arr2 scaffold to different signaling pathways; however, this is often cell type-specific and receptorspecific. Overexpression of either β-arr1 or β-arr2 led to marked inhibition of NF-κB activity. 25 Conversely, suppression of β-arr1, but not β-arr2, using RNA interference led to a threefold increase in tumor necrosis factor (TNF)-stimulated NF-κB activity, as measured by NF-κB mobility-shift analysis. 25 Our study also found that β-arr1 protects against endoplasmic reticulum stress/p53-upregulated modulation of apoptosis via repression of p-p65/inducible nitric oxide synthase in portal hypertensive gastropathy. 26 However, it is unclear whether β-arrs are involved in AP through the activation of NF-_x04A1;Bp65.
In our study, we demonstrated here that β-arr1 plays a crucial protective role in AP via repression of NF-_x04A1;Bp65 activation. Therefore, β-arr1 is a potential therapeutic target for AP.
Materials and methods
Mouse models of acute pancreatitis. The study is in compliance with ethical standards, and the procedures for all animal experiments were approved by the Institutional Animal Care and Use Committee at The Third Affiliated Hospital of Sun YatSen University. β-arr1 wild-type (WT) and β-arr1 knockout (KO) littermates on a C57BL/6 background were generated from heterozygote intercrosses. Two experimental mouse models that cause pancreatitis were utilized. (i) Caerulein-induced pancreatitis: 6-to 8-week-old female mice (13-17 g) were fasted from solid food for 12-16 h (but were allowed water ad libitum) and then received seven-hourly intraperitoneal injections of phosphate-buffered saline or 50 μg/kg caerulein (50 μg/kg in 0.2 mL of phosphatebuffered saline, Sigma, St Louis, MO, USA). 27, 28 (ii) Cholinedeficient supplemented with ethionine diet (CDE) induced pancreatitis: 3-to 4-week-old female mice (11-16 g ) were fasted as mentioned previously, were fed CDE (MP, Irvine, CA, USA) chow for 3 days then switched to a normal diet. 29, 30 For the caerulein-induced models, the mice were examined at different time point, then anesthetized and euthanized. Blood samples were obtained by retro-orbital puncture, and the entire pancreas from each mouse in each group was carefully removed and immediately stored at À80°C for protein or RNA analysis. For preparing paraffin sections, the entire pancreas from each mouse in each group was carefully isolated and immediately fixed in 10% neutral buffered formalin before embedding. For the CDE models, the mice were examined for up to 7 days to court the survival rate.
Histopathological analysis. Tissue sections (4 μm) of pancreas were stained with hematoxylin-eosin for histological analysis. Histological scores were blindly determined based on the previously described criteria. The entire sections were examined for each sample. The extent and severity of edema, inflammatory cell infiltrate, and acinar necrosis were graded from 0 to 3. The global scores were summarized by two independent investigators. 31 Measurement of serum amylase level. Blood samples for determining serum amylase were obtained after mice were anesthetized. The level of amylase from serum was measured using an assay kit (BioAssay Systems, Hayward, CA, USA) according to the manufacturer's instructions.
Myeloperoxidase activity estimation. Myeloperoxidase (MPO) was measured using an MPO activity colorimetric assay kit (Biovision, Milpitas, CA, USA) according to the manufacturer's instructions. The absorbance was measured at 450 nm, and MPO activity was expressed as units per milligram of protein.
Immunohistochemical staining. For immunohistochemical (IHC) staining, paraffin-embed pancreas sections were deparaffinized, rehydrated, and treated with 3% hydrogen peroxide. Antigen retrieval was performed by boiling the sections for 2 min in Tris/ethylenediaminetetraacetic acid antigen retrieval solution (pH 8.0). Nonspecific antibody binding was blocked using 15% goat serum for 30 min. For staining of tissue samples, the slides were incubated with primary antibody against MPO (1:200, Santa Cruz, Santa Cruz, CA, USA) or p-NF-κBp65 (1:100, Abcam, Cambridge, MA, USA). For IHC staining, the targeted protein was detected using secondary antibodies followed by detection using the ABC staining system (Santa Cruz). The sections were counterstained with hematoxylin.
Real-time polymerase chain reaction. Total RNA was isolated from pancreas samples using the RNAgents Total RNA Isolation System (Promega, Madison, WI, USA) according to the manufacturer's instructions. First strand cDNA was synthesized using Superscript Reverse Transcriptase (Invitrogen, Carlsbad, CA, USA) according to the manufacturer's instructions. Real-time polymerase chain reaction (PCR) was performed on a Chromo 4 Detector System (MJ Research, Sierra Point, CA, USA) using gene-specific primers and DyNAmo SYBR Green Master Mix (Finnzymes, Finland). Relative RNA was amplified using the following primers: TNF-α exon 3F, 0 . As the internal control, the expression of β-actin in each sample was quantified using the sense primer 5 0 -GTG GGC CGC TCT AGG CAC CA-3 0 and the antisense primer 5 0 -CGG TTG GCC TTA GGG TTC AGG GGG G-3 0 . Tissues from five mice were used in each group.
Western blot analysis. Total protein extraction was analyzed by western blot analysis. Antibodies that recognize β-actin (Santa Cruz), p-NF-κBp65, NF-κBp65, β-arr-1, and β-arr2 (all from Abcam) were used for western blot analysis. Appropriate horseradish peroxidase-conjugated secondary antibodies (Santa Cruz)
were used to detect the primary antibody/antigen complexes. The signal was detected using ECL western blot detection reagents (Amersham Pharmacia Biotech, Piscataway, NJ, USA). After quantifying the signals by densitometry, the results were expressed as a ratio to the loading control densitometry units.
Cell culture, drugs administration and cell transfection with short interfering RNA. The pancreatic acinar cell line (AR42J) and human pancreatic cancer cell line (PANC-1) were obtained from the American Type Culture Collection (Manassas, VA, USA). AR42J cells and PANC-1 cells were cultured in Dulbecco's modified Eagle's medium (Sigma) supplemented with 10% heat-inactivated fetal bovine serum (Invitrogen, Carlsbad, CA, USA) in a humidified 5% CO 2 incubator at 37°C. The media for all cell lines contained 100 U/mL penicillin, 100 μg/mL streptomycin, and 2.5 μg/mL amphotericin B. Caerulein (at a concentration gradient of 0, 10, 20, 50, 100, 200 nmol/L at time points of 0, 0.5, 1, 2, 4, 6 h, Sigma) was added Figure 1 β-Arrestin1 (β-arr1) expression was downregulated in caerulein-induced acute pancreatitis. (a) Mice were injected with caerulein (50 μg/kg, intraperitoneal) seven times at hourly intervals and euthanized at different time points (12 and 24 h). Pancreata were fixed and sectioned, then stained with hematoxylin and eosin. All time points are given an hour after the first injection, and control mice were euthanized at 24 h after vehicle administration (seven times phosphate-buffered saline injections). (b) Hematoxylin and eosin-stained pancreata were subjected to histological scoring (see Materials and methods section) at the indicated time points. Data are presented as the mean ± SD (n = 5 per time point), *P < 0.05 versus control group. (c) Myeloperoxidase (MPO) activity was measured after injection using an MPO activity colorimetric assay kit at the indicated time points. Data are presented as the mean ± SD (n = 5 at each time point), *P < 0.05 versus control group. (d) Serum amylase levels after caerulein or phosphate-buffered saline injection were measured using an assay kit at the indicated time points. Data are presented as the mean ± SD (n = 5 at each time point), *P < 0.05 versus control group. (e) Real-time polymerase chain reaction for β-arr1 mRNA expression in the pancreas after caerulein treatment. Data are presented as the mean ± SD (n = 5 at each time point). (f) Western blot analysis for β-arr1 or β-arr2 expression in the pancreas at the indicated time points. β-Actin was used as the loading control.
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after these cells had grown to a density of 90%. For short interfering RNA (siRNA) treatment, the cells were cultured in a 24-well plate and transfected with 20 μM β-arrestin1 RNA oligo kit (GenePharma, China) according to the manufacturer's instructions. After incubation for 24 h, the transfection medium was replaced by regular culture medium before caerulein administration.
Statistical analysis. Normal distribution data are reported as the means ± SD. Student's t-test was used to compare mean values between two groups, while the Mann-Whitney U-test was used to compare the mean rank between two groups with abnormal distribution data. Mouse survival rate was assessed using the log-rank test. Statistical comparisons were made using SPSS 13.0. P < 0.05 was considered statistically significant.
Results β-Arrestin1 expression was downregulated in caerulein-induced acute pancreatitis. We investigated pancreatic β-arrs expression in response to caerulein-induced AP. In this model, edema, cell death, and infiltrating inflammatory cells were observed, and obvious pancreas damage was noted 12 to 24 h after the first of seven-hourly caerulein injections (Fig. 1a) . The histologic scores increased at both 12 and 24 h (Fig. 1b) . The histologic MPO activity increased at 12 h and further increased at 24 h after caerulein treatment (Fig. 1c) . The serum amylase levels significantly increased at 12 h and gradually decreased at 24 h (Fig. 1d) . Real-time PCR showed that β-arr1 mRNA was significantly downregulated after caerulein treatment (Fig. 1e) . However, β-arr2 mRNA levels were not changed after caerulein treatment (f) Histological scores were determined by analysis of H&E stained sections, as described in the Materials and Methods section. Data are presented as the mean ± SD (n = 9 per group), *P < 0.05 versus control injection group, # P < 0.05 ( ) β-arr1 WT versus ( ) β-arr1 KO mice. (g) Three-to four-week old female (12-16 g) ( ) β-arr1 WT and ( ) β-arr1 KO mice were fed choline-deficient supplemented with ethionine diet (CDE) for 3 days, then switched to a normal diet. The survival rates of β-arr1 KO and β-arr1 WT mice were calculated. P = 0.0147, β-arr1 KO versus β-arr1 WT mice.
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(data not shown). Further, western blot analysis showed that only the expression of β-arr1, but not β-arr2, was significantly downregulated at the indicated time points after caerulein treatment (Fig. 1f) . These results indicated that β-arr1 plays an important role in experimental AP.
β-Arrestin1 deficiency aggravated caerulein and choline-deficient supplemented with ethionine diet-induced acute pancreatitis. To investigate the role of β-arr1 in AP, we compared the pancreas injuries between β-arr1 WT and β-arr1 KO littermate mice 12 h after the caerulein-induced pancreatitis treatment. Pathological alternations were more severe in β-arr1 KO mice (Fig. 2a) , especially regarding inflammatory cell infiltrate and necrosis. Additionally, pancreatic MPO IHC and pancreatic MPO activity also indicated increased inflammatory cell infiltration (Fig. 2b,d ). Serum amylase levels were significantly increased in β-arr1 KO mice compared with β-arr1 WT mice (Fig. 2c) . However, the pancreatic weight/body weight ration showed that the edema was slightly increased in β-arr1 KO mice compared with WT mice (Fig. 2e ).
To determine a histological score, the entire pancreas of mice from each group was examined and semiquantified on the basis of necrosis, inflammation, and edema from hematoxylin-eosin staining. Collectively, the data showed that the global histological scores were higher in β-arr1 KO mice than in WT mice (Fig. 2f) . To further investigate the role of β-arr1 in the mouse survival rate, the survival rate was evaluated in the CDE-induced pancreatitis model and compared between WT and KO littermate mice. CDE feeding caused extensive pancreatic damage and mouse death within 2 days (30.0% β-arr1 KO mice vs 7.0% β-arr1 WT mice), and the total survival rate was 20.0% in β-arr1 KO mice vs. 60% in WT mice (Fig. 2g) . Our data suggest that β-arr1 deficiency aggravated caerulein-induced and CDEinduced AP.
β-Arrestin1 downregulated proinflammation cytokines in caerulein-induced acute pancreatitis. To further understand the effects of β-arr1 in the AP inflammatory response, we examined cytokine expression in WT and KO mice. Cytokines are critical mediators of acute inflammatory responses in pancreatitis. Several cytokines have been implicated in the caerulein model of pancreatitis, and some studies have shown that IL-1β, TNF-α, IL-6, and IL-10 in particular play critical roles in the pathogenesis of both animal and human pancreatitis. [32] [33] [34] As predicted, the pancreatic IL-1β, TNF-α, and IL-6, but not IL-10, mRNA levels were elevated in the caerulein-induced models. Pancreatic IL-1β, TNF-α, and IL-6 were markedly increased in β-arr1 KO mice as compared with β-arr1 WT mice (Fig. 3a-c) . However, pancreatic IL-10 mRNA levels were distinctly increased in the β-arr1 WT mice as compared with the β-arr1 KO mice (Fig. 3d) . Taken together, these results showed that β-arr1 suppressed IL1βand TNF-αas well as IL-6 expression and upregulated IL-10 expression to protect caerulein-induced pancreatic damage.
Targeted deletion of β-arrestin1 promoted NF-κBp65 phosphorylation in cerulein-induced acute pancreatitis. Previous studies have shown positive or negative regulatory roles of β-arr1 in the NF-κB pathway. 25 Furthermore, studies have also shown that NF-κB signal pathways are critical mediators of inflammatory signaling in models of AP. [5] [6] [7] We examined the levels of phosphorylated NFκBp65 (p-p65) in pancreas tissue of caerulein-induced mice using western blot analysis and IHC. We found that pancreatic p-p65 was upregulated following cerulean treatment (Fig. 4a,b) , and targeted deletion of β-arr1 promoted the p65 phosphorylation (Fig. 4a,c, and d) . Further, we observed that the pancreatic p-p65 was also significantly raised following CDE fed, and β-arr1 deficiency enhanced the p65 phosphorylation (data not shown). These data indicate that targeted deletion of β-arr1 promoted NF-κBp65 phosphorylation in cerulein-induced AP.
β-Arrestin1 downregulates caerulein-induced NF-κBp65 phosphorylation. To explore the mechanism of β-arr1 in response to NF-κBp65 phosphorylation (p-p65) in caerulein-induced pancreatitis, we focused on NF-κB function. NF-κB is important in the regulation of gene expression during inflammation and is reported to be activated in the pancreas. We performed our analysis using in vitro cultured pancreatic AR42J and PANC-1 cell lines. First, we assessed peak p-p65 in our experimental conditions after treating the cell lines with caerulein. As Figure 4 Targeted deletion of β-Arrestin1 (β-arr1) promoted NF-κBp65 phosphorylation in cerulein-induced acute pancreatitis. (a) Immunohistochemical (IHC) staining for p-p65 in the indicated pancreas sections from β-arr1 wild-type (WT) and β-arr1 knockout (KO) mice (brown). (b) Western blot analysis for p-p65 expressions in the pancreas at the indicated time points in β-arr1 WT mice. p65 and β-actin were used as the loading controls. (c) Western blot analysis for p65 and p-p65 expression levels in the pancreas of β-arr1 WT and β-arr1 KO mice with the indicated treatments. β-actin was used as the loading control. Five mice were studied, and the representative data were presented. (d) Quantitative analysis of the p-p65/p65 ratio was measured by densitometry scanning of the western blot. Data are presented as the mean ± SD (n = 5 per group). *P < 0.05 versus control injection group, # P < 0.05
alleviates acute pancreatitis shown in Figure 5 , peak p65 phosphorylation occurred after a 100-nM caerulein treatment for 4 h in both cell lines (Fig. 5a-d) . We then silenced the β-arr1 gene using siRNA in both AR42J and PANC-1 cell lines and investigated NF-κBp65 phosphorylation using western blot analysis. After β-arr1 siRNA, the two cell lines were exposed to 100-nM caerulein for 4 h. We found that β-arr1 expression was downregulated after siRNA silencing. Furthermore, p-p65 was upregulated after caerulein challenge (Fig. 5e-f) . These results demonstrated that β-arr1 downregulates caerulein-induced NF-κBp65 phosphorylation.
Discussion
The etiology and pathogenesis of AP in humans have not been fully elucidated, and its mechanism is extremely unclear, especially in regard to acinar injury. The disease begins with pancreatic acinar injury, and then, a local and systemic inflammatory response evolves quickly that may even prove to be fatal. 35 Despite some differences between human AP and mouse models of pancreatitis, the caerulein-induced and CDE-induced pancreatitis models in mice have generally been useful in determining the roles of signaling proteins in the pathogenesis of pancreatitis. [27] [28] [29] [30] The caerulein-induced pancreatitis model is especially useful in determining the molecular signaling pathways. With the present study, we provided the first evidence that the scaffolding cell signaling protein β-arr1 plays an important role in both mouse models of pancreatitis. Although, β-arr1 was originally discovered for its role in GPCR desensitization, recent studies (including some from our laboratory) demonstrated that β-arr1 had a broader role in cell signaling that was not restricted to GPCR desensitization. In this regard, we recently reported that β-arr1 enhanced inflammationmediated Akt signaling. 36 Other studies have reported that β-arr1 positively or negatively regulated the inflammatory response in vivo or in vitro.
21,22 Therefore, we studied whether β-arr1 is involved in AP.
In this study, caerulein injection caused AP as evidenced by increased serum amylase levels, elevated MPO activity, and distinct pathological changes at different time points. Our data showed that caerulein-induced pancreas inflammation suppressed β-arr1 expression over the time course, and β-arr1 deficiency significantly aggravated AP. The survival rate was significantly decreased in β-arr1 depleted mice in CDE-induced acute hemorrhagic pancreatitis. These results revealed that β-arr1 downregulates AP.
Cytokines play a major role in the development of inflammation and necrosis during both the experimental mouse AP model and human AP. Experimentally, blocking the proinflammatory cytokine cascade, even after the initiation of pancreatitis, results in a dramatic decrease in the severity of AP. [32] [33] [34] IL-1β, TNF-α, and After incubation for 24 h, the transfection medium was replaced by regular culture medium, and then, cells were treated with 100 nM caerulein for 0 or 4 h. β-Arr1, p65, and p-p65 expressions were analyzed by western blot. β-Actin was used as the loading control.
IL-6 have been shown to be implicated in the promotion of inflammation and acinar necrosis in different models of AP. However, IL-10 plays a protective role in pancreatic inflammation and necrosis. In our study, we found that IL-1β, TNF-α, and IL-6 mRNA levels were significantly elevated, whereas IL-10 levels were significantly decreased in β-arr1 deficient mice as compared with WT mice after caerulein challenge. Taken together, these results suggested that β-arr1 protects caerulein-induced AP via suppression of IL-1β, TNF-α, and IL-6 expression and increased IL-10 expression. Nuclear factor-κB activation has been observed early in the onset of pancreatitis, and it parallels trypsinogen activation. 37, 38 NF-κB is a ubiquitous transcription factor and pleiotropic regulator of numerous inflammatory processes. Once activated, NF-κB translocates from the cytosol to the nucleus, where it activates the transcription of a spectrum of proinflammatory genes. Early intra-acinar NF-κB activation appears to be the key step in the pathogenesis of inflammation in pancreatitis. Although NF-κB is a key regulator of cytokine expression in different cell types, few reports link NF-κB and β-arr1 in AP. Our in vivo results showed that β-arr1 KO remarkably aggravated caerulein-induced and CDE-induced AP, and NF-κBp65 phosphorylation was increased. In addition, in vitro results also showed that suppression of β-arr1 using siRNA led to increased NF-κBp65 phosphorylation after caerulein treatment. Therefore, our results provided evidence for that the induction of NF-κB activation in the pancreas is regulated in part by β-arr1.
In summary, our results demonstrated that β-arr1 protects the pancreas from both the damaging caerulein-triggered inflammatory response and CDE-induced mortality. β-arr1 was a critical protective mediator in AP via regulation of NF-κBp65 phosphorylation. These results suggested that β-arr1 plays a crucial protective role on AP by repressing NF-_x04A1;Bp65 activation and that β-arr1 is a potential therapeutic target for AP.
